Eugene

[email protected]

LATEST

Mayne Pharma Opens $80-Million Oral Solid-Dose Mfg Facility
By

By
Mayne Pharma, a Salisbury South, Australia-headquartered pharmaceutical company reports that it and its contract development and manufacturing business, Metrics Contract Services, have opened a new $80-million, oral solid-dose commercial manufacturing…

Shire Confirms Conditional Acquisition Proposals by Takeda; Rejects Proposals and Continues Talks
By

By
Shire has confirmed that it received three conditional acquisition proposals from Takeda, on March 29, 2018 (the first proposal), April 11, 2018 (the second proposal), and April 13, 2018 (the…

Merck KGaA To Sell Consumer Health Business to P&G for $4.2 Billion
By

By
Procter & Gamble (P&G) has agreed to acquire the consumer health business of Merck KGaA, for approximately EUR 3.4 billion ($4.2 billion). The acquisition provides P&G with healthcare commercial and…

Roche Leads Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Roche. Editor’s Note: This article was updated on a continuous basis for news…

GE Launches New Mfg Service for Viral Vector-Based Therapies
By

By
GE Healthcare is launching a service, KUBio BSL2, that allows manufacturers to build a prefabricated modular manufacturing facility for viral vector-based therapeutics, including oncolytic vaccines and cell and gene therapies,…

Novartis Invests $100 million To Develop Antimalarials
By

By
Novartis plans to invest more than $100 million to advance research and development (R&D) of treatments for malaria. The company also plans to implement an equitable pricing strategy to maximize…

Roche’s Genentech, Kineta in $359-million Pact for Non-Opioid Pain Therapy
By

By
Genentech, a Roche company, has signed an option and license agreement with Kineta Chronic Pain, a subsidiary of Kineta, a biopharmaceutical company, to develop Kineta’s α9/α10 nicotinic acetylcholine receptor (nAChR)…

Sanofi To Sell European Generics Business for $2.4 Billion
By

By
Sanofi and Advent International, a Boston-based private-equity firm, have entered into negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for EUR 1.9 billion ($2.4 billion)​. Advent will…

ACG Biologics Names GM of Bothell Site
By

By
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, has appointed Jin Wang, PhD, as Site Head/General Manager of its Bothell, Washington operations. Wang, who will provide…

Almac Group Expands Specialized Commercial Packaging
By

By
Almac Group, a Craigavon, UK-based contract development and manufacturing organization, has expanded its US commercial packaging capabilities at its Audubon, Pennsylvania facility. Almac Pharma Services has added technology for the…